EDMONTON, ALBERTA--(Marketwire - May 13, 2008) - ViRexx Medical Corp. (TSX: VIR)(AMEX: REX), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumours, today announced its financial and operational results for the three-month period ended March 31, 2008.
